2018
DOI: 10.1002/hsr2.34
|View full text |Cite
|
Sign up to set email alerts
|

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome

Abstract: AimTo review the initial effectiveness of bovine lipid extract surfactant (BLES) for the treatment of respiratory distress syndrome in preterm infants.Methods and resultsA retrospective review of data collected from infants born <37‐week gestation with respiratory distress syndrome treated with BLES between February 1, 2015 and March 1, 2016. Data were analyzed to determine the timing of initial dose, the length of time to wean the fraction of inspired oxygen (FiO2) concentration to 0.21 following initial dose… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…Building on these studies we used a modified natural surfactant, exposed the samples to EC generated aerosols, and focused on the main function of surfactant by measuring surface tension reduction. Specifically, we used BLES, a well-established commonly prescribed exogenous surfactant composed of the surfactant lipids and the hydrophobic proteins B and C [ 31 ]. Aerosol exposure was performed in a syringe containing a surfactant suspension allowing direct exposure of surfactant to the aerosol.…”
Section: Discussionmentioning
confidence: 99%
“…Building on these studies we used a modified natural surfactant, exposed the samples to EC generated aerosols, and focused on the main function of surfactant by measuring surface tension reduction. Specifically, we used BLES, a well-established commonly prescribed exogenous surfactant composed of the surfactant lipids and the hydrophobic proteins B and C [ 31 ]. Aerosol exposure was performed in a syringe containing a surfactant suspension allowing direct exposure of surfactant to the aerosol.…”
Section: Discussionmentioning
confidence: 99%
“…Altogether, these trials enrolled 692 infants and some type of ETT obstruction was reported in between 6 and 11% of infants treated with BLES® [19]. A retrospective single center study done in Canada investigated the time to reach room air following BLES® administration in infants <37 weeks and no side effects were identified [21]. In the only prospective study, we described an incidence of 15% of SAO, mostly in extremely low birthweight infants (83%), an incidence similar to the Canadian RCT [19].…”
Section: Discussionmentioning
confidence: 99%
“…Despite the bovine lipid extract surfactant being a low-cost preparation used for several years, only six clinical studies were performed: four randomized controlled trials (RCT) [ 9 , 18 – 20 ], one prospective observational study [ 10 ] and one retrospective single center analysis [ 21 ]. Unfortunately, except for one study [ 10 ], details on the surfactant administration technique is not provided and reports on major adverse effects were quite variable.…”
Section: Discussionmentioning
confidence: 99%